fda glp-1 compounding enforcement september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA issued 25 warning letters

It interacts with specific receptors on the surface of immune cells and endothelial cells to modulate physiological processes such as inflammation, immune response, and dilation of blood vessels

High-dose PLGA-encapsulated IGF-1 LR3 at 280 g produced statistically significant increases in muscle wet weight at 28 days post-implantation compared to vehicle controls

2 capsules per serving provide 1,000mg of top-grade reduced glutathione for daily balance

Osbak PS, Mourier M, Henriksen JH, Kofoed KF, Jensen GB

Trulicity should not be used by people with type 1 diabetes, people with diabetic ketoacidosis, or people with a history of severe stomach or intestinal problems